Jingsong Wang

Founder, Chairman & Chief Executive Officer at Harbour BioMed

Mr. Jingsong Wang, M.D., Ph.D., is the Principal Founder, Chairman and Chief Executive Officer. Prior to founding the company, Dr. Wang served as Head of China R&D and Head of Translational Medicine, Asia Pacific, at Sanofi. He is a former attending physician and clinical fellow at Harvard Medical School. Dr. Wang received his Ph.D. in Molecular Pharmacology from China Pharmaceutical University and has also completed a Molecular Immunology Research Fellowship at Dr. Laurie Glimcher ’s laboratory at the Harvard School of Public Health.

Location

Cambridge, United States

Links

Previous companies


Org chart


Teams


Offices


Harbour BioMed

1 followers

Harbour BioMed is an Immune-Driven Global Bio-therapeutics Company discovering, developing and delivering Innovative Therapeutics for Oncology and Immunology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery - the H2L2 and the HCAb.


Industries

Employees

201-500

Links